Hasil Pencarian - Chih-Hsin Yang

Perbaiki Hasil
  1. 1
    Second-line treatment of T790M-negative non-small cell lung cancer patients

    Second-line treatment of T790M-negative non-small cell lung cancer patients oleh Bin-Chi Liao, Sebastian Griesing, James Chih-Hsin Yang

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    First-line afatinib for the treatment of mutation-positive non-small-cell lung cancer in the ‘real-world’ clinical setting

    First-line afatinib for the treatment of mutation-positive non-small-cell lung cancer in the ‘real-world’ clinical setting oleh Keunchil Park, Darren Wan-Teck Lim, Isamu Okamoto, James Chih-Hsin Yang

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation

    The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation oleh Shang-Gin Wu, Chong-Jen Yu, James Chih-Hsin Yang, Jin-Yuan Shih

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Treating patients with -positive non-small cell lung cancer: latest evidence and management strategy

    Treating patients with -positive non-small cell lung cancer: latest evidence and management strategy oleh Bin-Chi Liao, Chia-Chi Lin, Jin-Yuan Shih, James Chih-Hsin Yang

    Diterbitkan 2015-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The Role of Interleukin 1β in the Pathogenesis of Lung Cancer

    The Role of Interleukin 1β in the Pathogenesis of Lung Cancer oleh Edward B. Garon, MD, James Chih-Hsin Yang, MD, PhD, Steven M. Dubinett, MD

    Diterbitkan 2020-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Pemetrexed for Heavily Pretreated Patients With Advanced Non-small Cell Lung Cancer

    Pemetrexed for Heavily Pretreated Patients With Advanced Non-small Cell Lung Cancer oleh Jih-Hsiang Lee, Chong-Jen Yu, Kuan-Yu Chen, Jin-Yuan Shih, Yu-Lin Lin, Chih-Hsin Yang

    Diterbitkan 2010-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Characteristics and Risk Factors of Oxaliplatin-related Hypersensitivity Reactions

    Characteristics and Risk Factors of Oxaliplatin-related Hypersensitivity Reactions oleh Yu-Yun Shao, Fu-Chang Hu, Jin-Tung Liang, Wen-Tzu Chiu, Ann-Lii Cheng, Chih-Hsin Yang

    Diterbitkan 2010-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients – A Taiwanese study

    Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients – A Taiwanese study oleh Ting-Hui Wu, Lukas Jyuhn-Hsiarn Lee, Chang-Tsu Yuan, Tom Wei-Wu Chen, James Chih-Hsin Yang

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study

    Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study oleh Gee-Chen Chang, Chun-Ming Tsai, Te-Chun Hsia, Chih-Hsin Yang, Radhi Abdulnabi, Julie M. Blair, Carlos Linn

    Diterbitkan 2013-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer

    Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer oleh Shao-Lun Lu, Feng-Ming Hsu, Kuan-Yu Chen, Chao-Chi Ho, James Chih-Hsin  Yang, Jason Chia-Hsien Cheng

    Diterbitkan 2016-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Enhancing Anticancer Effect of Gefitinib across the Blood–Brain Barrier Model Using Liposomes Modified with One α-Helical Cell-Penetrating Peptide or Glutathione and Tween 80

    Enhancing Anticancer Effect of Gefitinib across the Blood–Brain Barrier Model Using Liposomes Modified with One α-Helical Cell-Penetrating Peptide or Glutathione and Tween 80 oleh Kuan-Hung Lin, Shu-Ting Hong, Hsiang-Tsui Wang, Yu-Li Lo, Anya Maan-Yuh Lin, James Chih-Hsin Yang

    Diterbitkan 2016-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement—Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors

    Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement—Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors oleh Ming-Hung Huang, PhD, Jih-Hsiang Lee, MD, Pei-Shan Hung, PhD, James Chih-Hsin Yang, MD, PhD

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides

    Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides oleh Shu-Ting Hong, Huaching Lin, Chen-Shen Wang, Chih-Hsien Chang, Anya Maan-Yuh Lin, James Chih-Hsin Yang, Yu-Li Lo

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells.

    Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells. oleh Mei-Chuan Tang, Mei-Yi Wu, Ming-Hung Hwang, Ya-Ting Chang, Hui-Ju Huang, Anya Maan-Yuh Lin, James Chih-Hsin Yang

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Skin manifestations of gefitinib and the association with survival of advanced non-small-cell lung cancer in Taiwan

    Skin manifestations of gefitinib and the association with survival of advanced non-small-cell lung cancer in Taiwan oleh Shiou-Han Wang, Chih-Hsin Yang, Hsien-Ching Chiu, Fu-Chang Hu, Chih-Chieh Chan, Yi-Hua Liao, Hsiao-Chin Chen, Chia-Yu Chu

    Diterbitkan 2011-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report

    Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report oleh James Chih-Hsin Yang, Martin Schuler, Sanjay Popat, Sanjay Popat, Satoru Miura, Keunchil Park, Antonio Passaro, Filippo De Marinis, Flavio Solca, Angela Märten, Edward S. Kim

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases.

    The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases. oleh Yun Chiang, James Chih-Hsin Yang, Feng-Ming Hsu, Yu-Hsuan Chen, Jin-Yuan Shih, Zhong-Zhe Lin, Keng-Hsueh Lan, Ann-Lii Cheng, Sung-Hsin Kuo

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    459 Phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1–positive metastatic NSCLC

    459 Phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1–positive metastatic NSCLC oleh Matthew Hellmann, Ying Cheng, Toshiaki Takahashi, Gilberto de Castro, M Catherine Pietanza, James Chih-Hsin Yang, Byoung Cho, Rosalyn Juergens, Mustafa Erman, Jessica Bauman, Paul Schwarzenberger, Pingye Zhang

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front‐line chemotherapy regimens

    Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front‐line chemotherapy regimens oleh Wei‐Li Ma, Chia‐Chi Lin, Feng‐Ming Hsu, Jang‐Ming Lee, Jin‐Shing Chen, Yen‐Lin Huang, Yih‐Leong Chang, Chin‐Hao Chang, James Chih‐Hsin Yang

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer

    Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer oleh Charles M. Rudin, Martin Reck, Melissa L. Johnson, Fiona Blackhall, Christine L. Hann, James Chih-Hsin Yang, Julie M. Bailis, Gwyn Bebb, Amanda Goldrick, John Umejiego, Luis Paz-Ares

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: